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Abstract 
Goal: Determination of sensitivity of Group B streptococcus (GBS) 
isolates to penicillin, erythromycin, clindamycin, tetracycline and 
vancomycin. 
Material: The study was done with female patients from Bitola, 
Macedonia during the period of 10/2010-05/2013 that included 132 
patients. 42 of the patients were pregnant and routinely screened 
between the 35-37 gestational week for the presence of GBS, and the 
rest of the patients were tested because they already had symptoms 
from GBS infection. 
Expected results: The results in the study are expected 
to show that GBS has a high percentage of resistance toward certain 
antibiotics. This information is expected to raise awareness in the 
country for the importance of the testing of the antibiotic resistance of 
GBS, and to advocate for specific protocols to be prepared and 
recommended by the Ministry of Health that will help properly prevent or 
treat infection with GBS in patients.  
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Test  ChiSquare Prob>ChiSq
  
Likelihood Ratio 144.498 <.0001*  
Pearson  117.676 <.0001*  
Means and Std Deviations 
Level Number Mean Std Dev Std Err   
                                         Mean    
R 46 36.4130 12.8713 1.8978  
S 88 37.5909 12.5457 1.3374  
  
Test ChiSquare Prob>ChiSq  
Likelihood Ratio 1.755 0.1853  
Pearson  1.711 0.1908  
Hypothesis: there is relationship between the sensitivity of Erythromycin 
and Clindamycin 
Chi square is <0.0001 which proves the hypothesis true that there is a strong 
positive relationship between the two antibiotics, and the 
sensitivity/resistance of one is a good predictor of the sensitivity/resistance 
of the other one.  
Hypothesis: There is a difference in the age group of patients who are sensitive or 
resistant to Erythromycin. 
The t-test for erythromycin by age, shows us that there isn’t a significant 
difference in the age group of patients who are sensitive or resistant to 
Erythromycin. The mean age of patient resistant to Erythromycin is 36.4, and the 
mean of patients who are not resistant is 37.5. The p value of 0.6132 also confirms 
that the hypothesis is false.  
Is the resistance level of GBS high enough to alarm the health authorities? 
25% of pregnant women are treated with the wrong 
antibiotic! This is very alarming, because this 
practice risks the chance for newborns to be infected 
with GBS which can lead to sepsis(infection of the 
blood), pneumonia (infection of the lungs) or 
meningitis, all serious conditions that can 
compromise the life of the baby.  
The Chi square test shows that the percentage of 
patients who are infected with GBS that is resistant to 
Erythromycin therapy starts at 25% and goes as high as 
60%! Even though the Chi Square Person value is not 
significant enough, it does show that conducting an 
antibiotic sensitivity test for GBS would significantly 
decrease the percentage of patients who are treated with 
the wrong therapy. 
Conclusion: This study shows alarming results in the level of resistance of Group B streptococcus to Erythromycin and Clindamycin. By the current recommendation of the Ministry of Health in Macedonia, 
these two antibiotics are prescribed to patients who have allergy to Penicillin without testing for antibiotic sensitivity because of the cost of testing. As seen from the results, 25% of pregnant women and 30% of women 
who are not pregnant are treated with an antibiotic that is not effective in treating GBS. Wrong treatment is especially dangerous in pregnant women who can pass GBS to their babies as infection with GBS in newborns 
can seriously threaten the life and health of the newborn. GBS is proven to be always sensitive to penicillin and vancomycin therapy and always resistant to tetracylcline. In addition, the resistance/sensitivity to 
Clindamycin and Erythromycin is the same in most cases. A possible solution to the cost of testing, therefore, would be doing one single test to determine GBS sensitivity to either Erythromycin or Clindamycin. 
 
Among the 5 antibiotics used to treat GBS, penicillin and vancomycin are 
always successful and tetracycline is never successful. However, many 
people are allergic to penicillin, and vancomycin is given intravenously at 
the hospital which is inconvenient for patients and expensive. That is why 
Clindamycin and Erytromycin have become the standard therapy for patient 
with allerty to Penicillin  
Acknowledgements: Thanks to Elena Krstevska-Kelepurovska, M.D. Microbiology specialist from the Center for Public Health in Bitola, Macedonia for conducting the study, the Microbiology 
Department in the Center for Public Health in Bitola, Macedonia for giving me permission to use the data and Professor Kathleen Engelmann for her expertise in guiding me and inspiring me to make this poster.  
   
Prob > |t| 0.6132  
Test ChiSquare Prob>ChiSq  
Likelihood Ratio 6.565 0.0871  
Pearson  6.903 0.0751  
